OBIO vs SPY
Orchestra BioMed Holdings Inc. (OBIO) versus SPDR S&P 500 ETF Trust (SPY) — a side-by-side from cached financials, not a winner call.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
SPDR S&P 500 ETF Trust (SPY) common stock listed on US.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
SPY does not have a complete income-statement cache yet.
OBIO currently screens at market cap $231.7M. SPY currently screens at market cap $0.
Not investment advice. Open the OBIO and SPY stock pages for the full models.
Not investment advice.